title: The Why WAIT program: improving clinical outcomes through weight management in type 2 diabetes.
abstract: Targeting body weight, as an alternative model to targeting hemoglobin A(1c), is emerging as a viable and potentially cost-effective approach to diabetes management in clinical practice. Why WAIT (Weight Achievement and Intensive Treatment) is a 12-week multidisciplinary program for weight control and intensive diabetes management specifically designed for application in routine diabetes practice. The program, which is generally covered by insurance, is followed by continuous support aimed at long-term maintenance of weight loss and diabetes control. This model was effective in improving key metabolic abnormalities observed in diabetic patients. Eighty-two percent of participants achieved the target hemoglobin A(1c) of less than 7% on less diabetes medications. The achieved weight reduction after 12 weeks of intervention was maintained for an additional year. Future dissemination of this intervention model in routine clinical practice may require wider endorsement by third-party payers and support of governmental health care agencies to halt the progression of the epidemic of obesity and diabetes in the United States.
authors.affiliation: Joslin Diabetes Center, One Joslin Place, Boston, MA 02215, USA. Osama.Hamdy@joslin.harvard.edu
authors.forename: Osama
authors.initials: O
authors.lastname: Hamdy
authors.forename: Catherine
authors.initials: C
authors.lastname: Carver
mesh_terms: D001835:Body Weight / Q000502:physiology*; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000503:physiopathology / Q000517:prevention & control*; D006442:Glycated Hemoglobin / Q000032:analysis; D006293:Health Promotion / Q000379:methods; D006801:Humans; D008019:Life Style; D008875:Middle Aged; D016896:Treatment Outcome
chemical_list: D006442:Glycated Hemoglobin
references.citation: Int J Obes (Lond). 2005 Sep;29(9):1115-20
references.pmid: 15925953
references.citation: J Endocrinol Invest. 2005 Dec;28(11):973-7
references.pmid: 16483174
references.citation: Diabetes Care. 2003 Nov;26(11):2977-82
references.pmid: 14578226
references.citation: Int J Obes Relat Metab Disord. 1999 Nov;23(11):1170-7
references.pmid: 10578207
references.citation: Clin Pharmacokinet. 2008;47(1):7-20
references.pmid: 18076215
references.citation: Osteoporos Int. 2005 Dec;16(12):1703-12
references.pmid: 15937634
references.citation: Diabetes Care. 2002 Mar;25(3):425-30
references.pmid: 11874925
references.citation: N Engl J Med. 2002 Feb 7;346(6):393-403
references.pmid: 11832527
references.citation: Am J Prev Med. 1987 Nov-Dec;3(6):339-45
references.pmid: 3452374
references.citation: Diabetes Care. 2003 Jul;26(7):2119-25
references.pmid: 12832323
references.citation: Diabetes Obes Metab. 2004 Mar;6(2):85-94
references.pmid: 14746573
references.citation: Obes Res. 2002 Dec;10 Suppl 2:124S-130S
references.pmid: 12490661
references.citation: Curr Diab Rep. 2006 Nov;6(5):405-8
references.pmid: 17139804
references.citation: Diabetes Care. 1993 Jan;16(1):21-31
references.pmid: 8422777
references.citation: Curr Med Res Opin. 2007 Sep;23(9):2157-69
references.pmid: 17669232
references.citation: Diabetes Self Manag. 2005 Nov-Dec;22(6):40, 42-4
references.pmid: 16355469
references.citation: JAMA. 2002 Oct 9;288(14):1723-7
references.pmid: 12365955
references.citation: JAMA. 1999 Jun 2;281(21):2005-12
references.pmid: 10359389
references.citation: Gut. 2004 Mar;53(3):413-9
references.pmid: 14960526
references.citation: Diabetologia. 2004 Oct;47(10):1677-86
references.pmid: 15480538
references.citation: Diabetes Care. 2007 Jun;30(6):1374-83
references.pmid: 17363746
references.citation: Metabolism. 2004 Mar;53(3):284-9
references.pmid: 15015138
references.citation: Ethn Dis. 2007 Winter;17(1):35-9
references.pmid: 17274207
references.citation: Int J Clin Pract. 2008 Apr;62(4):659-65
references.pmid: 18324957
references.citation: J Am Soc Nephrol. 2006 Dec;17(12 Suppl 3):S213-7
references.pmid: 17130264
references.citation: Diabetologia. 2008 Mar;51(3):408-16
references.pmid: 18204830
references.citation: Obes Surg. 2006 Oct;16(10):1278-86
references.pmid: 17059735
references.citation: Nutr Metab (Lond). 2006 Mar 23;3:16
references.pmid: 16556307
references.citation: Diabetes Care. 1998 Sep;21(9):1414-31
references.pmid: 9727886
references.citation: Obes Res. 2003 Sep;11(9):1048-54
references.pmid: 12972674